Potassium, Blood Biomarker

Overview

A blood potassium test measures the concentration of potassium ions in the fluid portion of blood (serum or plasma), typically reported in mmol/L or mEq/L. Potassium is a major intracellular cation that is essential for maintaining cell membrane potential, normal muscle contraction, nerve conduction, and cardiac rhythm. Normal adult serum potassium is generally about 3.5 to 5.0 mmol/L; values below 3.5 mmol/L indicate hypokalemia and values above about 5.5 mmol/L indicate hyperkalemia. Low or high potassium levels are associated with muscle weakness, arrhythmias, and potentially life‑threatening cardiac complications. The test is clinically useful for evaluating electrolyte and acid–base disturbances, monitoring kidney and cardiovascular disease, assessing the safety of medications that affect potassium, and guiding acute and chronic treatment.

Clinical Use Cases

Evaluation of electrolyte balance and acid–base disorders, often as part of an electrolyte or basic metabolic panel.
Assessment and monitoring of kidney disease and kidney function, since impaired renal excretion commonly leads to hyperkalemia.
Diagnosis and monitoring of hyperkalemia (high blood potassium) and hypokalemia (low blood potassium), including classification of severity and treatment response.
Monitoring patients with heart disease, heart failure, or hypertension, especially when using diuretics, angiotensin‑converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), or other drugs that alter potassium.
Evaluation of cardiac arrhythmias or ECG changes suspected to be related to potassium abnormalities.
Monitoring potassium during diabetic ketoacidosis, severe dehydration, and intravenous fluid or potassium therapy to prevent dangerous shifts.
Investigation of causes of muscle weakness, paralysis, or periodic paralysis syndromes that may be associated with abnormal potassium levels.
Follow‑up of gastrointestinal losses (vomiting, diarrhea, laxative use) or endocrine disorders (for example, aldosterone excess) that can cause hypokalemia.

Specimen Types

Serum (most common for routine potassium testing).
Plasma (for electrolyte panels using anticoagulated blood).

Measurement Methods

Automated ion‑selective electrode (ISE) methods used in routine chemistry analyzers for serum or plasma potassium.
Point‑of‑care blood gas and electrolyte analyzers using ISE technology for rapid potassium measurement in acute care settings.

Test Preparation and Influencing Factors

Medications: Diuretics, ACE inhibitors, ARBs, potassium‑sparing diuretics, beta‑agonists, insulin, laxatives, and some antibiotics can raise or lower potassium and influence results.
Kidney function: Acute or chronic kidney disease reduces potassium excretion and predisposes to hyperkalemia.
Gastrointestinal losses: Vomiting, diarrhea, or nasogastric suction can cause hypokalemia through excessive potassium loss.
Hormonal and endocrine factors: Altered aldosterone, insulin, catecholamines, or acid–base status change potassium distribution and excretion.
Dietary intake and supplements: Very high or low potassium intake, salt substitutes containing potassium, and oral potassium supplements affect levels and should be reported to the clinician.
Sample handling and hemolysis: Hemolysis during blood draw or processing can falsely elevate serum potassium by releasing intracellular potassium from red blood cells.
Acid–base status and transcellular shifts: Metabolic acidosis, alkalosis, or changes in tonicity can shift potassium between intracellular and extracellular compartments, affecting measured levels.
Concurrent magnesium deficiency: Low magnesium can worsen or maintain hypokalemia despite supplementation and should be evaluated.
Fasting and timing: Routine potassium tests usually do not require fasting, but they are often drawn along with other fasting chemistry tests; timing may be coordinated with medication dosing for monitoring purposes.